Trim BKNG to 0.80x benchmark weight; $187 hard stop; abandon $205-207 sell trigger
Underweight at 0.80x benchmark weight is the calibrated verdict. Three converging streams — escalated deterioration evidence (MACD bearish cross, -2.81 histogram, 7.38M distribution volume persisting without capitulation), structural support arguments ($9B FCF, 7%+ shareholder yield, $17B cash, intact 200 SMA uptrend), and the prior-decision fingerprint constraints — converge on trimming with meaningful magnitude while constraining it to the lighter end. The Aggressive analyst is directionally correct on deterioration but overshoots with 0.75x and stale sell triggers; the Conservative analyst defends fundamentals well but underweights momentum regime shift information content; the Neutral analyst's 0.80x / $187 stop / abandon $205-207 framework is the correct synthesis. Option hedge premiums cannot keep pace with alpha decay that compounds beyond the 1%/week base rate.
| Position | Action |
|---|---|
| Current position above 0.80x benchmark weight | Trim 15-20% over next 1-3 sessions |
| Price rallies toward $199-201 (VWMA proximity) | Execute trim on relief bounce, not capitulation flush |
| Price reaches $200-202 | Reassess with fresh data; do not execute stale $205-207 sell trigger |
BKNG is a cash-generative compounder on sale at a technical decision point, with the 9.6% pullback from $215.69 creating a 2:1 risk/reward setup backed by 7%+ shareholder yield and no recession justify the underperformance.
| Indicator | Value | Signal |
|---|---|---|
| Close vs 10 EMA | 195.13 (below 202.11) | bearish |
| Close vs 50 SMA | 195.13 (just above 193.93) | neutral |
| Close vs 200 SMA | 195.13 (+5.3% above 185.33) | bullish |
| RSI (14) | 43.52 | neutral |
| MACD vs Signal | 1.07 vs 3.88 (bearish crossover) | bearish |
| MACD Histogram | −2.81 (expanding) | bearish |
| Bollinger Lower Band | 195.22 | neutral |
| Bollinger Middle Band | 207.85 | neutral |
| Bollinger Upper Band | 220.49 | neutral |
| VWMA | 206.02 (price 5.2% below) | bearish |
This report is AI-generated for informational and educational purposes only and is not investment advice or a recommendation to buy or sell any security. Full disclaimer.
When: Confirmed close >$208 on volume >7M shares with MACD histogram flipping back positive
Then: Re-engage to Hold or Overweight
Valuation is cheap for the quality of business
EV: +5% to +10.6% · concedes: International revenue is FX-exposed (EUR/JPY translation headwind); Google SEM dependency is a structural risk — though turned into a moat through scale; EU DMA 'gatekeeper' designation could force interoperability, though slow-moving and already partially priced in with no measurable margin impact to date; Airbnb's +21% surge in a month is real competition, though BKNG and ABNB are partially complements rather than pure substitutes; Post-Q2 drift of -3.6% reflects some profit-taking after the August rally; YTD -6.66% vs S&P +11.65% represents real underperformance against a melt-up tape
BKNG is in active distribution with technical breakdown confirming, revenue growth collapsed from 25% to 5%, macro is late-cycle stagflation not Goldilocks, and capital is rotating away from BKNG to ABNB — the risk/reward is 1:2 or worse to the downside, not the 2:1 the bull claims.
EV: -$175 to $185 (bear target for next 8–12 weeks) · concedes: Short-term tactical bounce possible toward $207 (mid-Bollinger) before failing; 7%+ total shareholder yield is real but already priced in; ATR is currently normal (not elevated) — though bear argues this will expand in breakdown
→ vs conservative: The conservative analyst's 200 SMA argument and 'long-term compounder thesis intact' framing is anchored to an 18-month-old thesis; of course the long-term thesis is intact in the abstract but the stock is mispricing the next 12 to 18 months, creating a 20 to 30% drawdown risk that the conservative analyst will later call a buying opportunity at the worst time
→ vs neutral: The neutral analyst's 'wait for confirmation at 193 to 195' is the most dangerous advice because RSI at 43 is not oversold, Bollinger lower band is a pivot not a floor, and waiting for confirmation means waiting for the rearview mirror to clear after the move has already occurred; the neutral stance is implicitly long and not truly neutral
| ATR (14) | 6.62 | neutral |
| Volume (9/3) | 7,375,682 | bearish |
Support: 195.22 · 193.93 · 185.33 | Resistance: 202.11 · 207.85 · 215.69 · 220.49
BKNG is mid-pullback from a 9.6% decline over 19 trading sessions, testing a critical confluence zone where the 50 SMA (193.93), Bollinger Lower Band (195.22), and current price (195.13) converge. Short-term momentum has flipped bearish with a fresh MACD crossover and expanding negative histogram, while long-term structure remains intact (price 5.3% above 200 SMA at 185.33). Volume of 7.38M is elevated vs. the 4–5M baseline, confirming distribution rather than quiet drift. The setup is symmetric risk/reward: bullish bounce target ~+10% to prior high of $215.69; bearish breakdown target ~−5% to 200 SMA at $185.33. Recommendation is HOLD for long-term positions and WAIT for tactical confirmation (bullish candle + RSI hook + MACD histogram contracting) before initiating new trades.
Market Cap
$146.6 B
Enterprise Value
~$148.2 B
52-Week High
$226.10
52-Week Low
$150.14
Beta
1.07
Dividend Yield
0.84%
Shares Outstanding
~1.61 B
Revenue FY2021
$17,090 M
Revenue FY2022
$21,365 M
Revenue FY2023
$23,739 M
Revenue FY2024
$26,917 M
Revenue TTM
$28,241 M
Revenue YoY Growth FY2022
+25.0%
Revenue YoY Growth FY2023
+11.1%
Revenue YoY Growth FY2024
+13.4%
Revenue YoY Growth TTM
~+4.9% run-rate
Revenue 4-yr CAGR
~13.5%
Operating Margin FY2022
29.8%
Operating Margin FY2023
30.7%
Operating Margin FY2024
31.8%
Operating Margin FY2025
32.8%
Operating Margin TTM
34.4%
EBITDA FY2022
$4,921 M
EBITDA FY2023
$7,043 M
EBITDA FY2024
$9,338 M
EBITDA FY2025
$9,217 M
EBITDA TTM
$10,413 M
Normalized EBITDA FY2022
$5,927 M
Normalized EBITDA FY2023
$7,522 M
Normalized EBITDA FY2024
$9,427 M
Normalized EBITDA FY2025
$10,956 M
Net Income FY2022
$3,058 M
Net Income FY2023
$4,289 M
Net Income FY2024
$5,882 M
Net Income FY2025
$5,404 M
Net Income TTM
$7,209 M
Normalized Net Income FY2025
~$6.78 B
Net Margin FY2022
17.9%
Net Margin FY2023
18.1%
Net Margin FY2024
21.9%
Net Margin FY2025
20.1%
Net Margin TTM
25.5%
FY2025 Unusual Items
$1.74 B
Loss on Sale of Securities
$1.28 B
Capital Asset Impairment
$457 M
ROA
20.4%
Sales & Marketing FY2025
$11.64 B
Sales & Marketing % of Revenue
~43%
G&A FY2025
$4.26 B
Salaries FY2025
$3.40 B
D&A FY2025
$623 M
Cash & Equivalents FY2022
$12,221 M
Cash & Equivalents FY2023
$12,107 M
Cash & Equivalents FY2024
$16,164 M
Cash & Equivalents FY2025
$17,203 M
Total Current Assets FY2022
$15,798 M
Total Current Assets FY2023
$17,034 M
Total Current Assets FY2024
$20,491 M
Total Current Assets FY2025
$22,264 M
Goodwill & Intangibles FY2022
$4,636 M
Goodwill & Intangibles FY2023
$4,439 M
Goodwill & Intangibles FY2024
$4,181 M
Goodwill & Intangibles FY2025
$3,587 M
Total Assets FY2022
$25,361 M
Total Assets FY2023
$24,342 M
Total Assets FY2024
$27,708 M
Total Assets FY2025
$29,264 M
Long-Term Debt FY2022
$11,985 M
Long-Term Debt FY2023
$12,223 M
Long-Term Debt FY2024
$14,853 M
Long-Term Debt FY2025
$16,856 M
Total Debt FY2022
$13,037 M
Total Debt FY2023
$14,783 M
Total Debt FY2024
$17,081 M
Total Debt FY2025
$19,293 M
Net Debt FY2022
$264 M
Net Debt FY2023
$2,077 M
Net Debt FY2024
$434 M
Net Debt FY2025
$1,533 M
Stockholders' Equity FY2022
+$2,782 M
Stockholders' Equity FY2023
−$2,744 M
Stockholders' Equity FY2024
−$4,020 M
Stockholders' Equity FY2025
−$5,578 M
Treasury Stock Balance YE2025
$54.3 B
Cumulative Stock Repurchases
~$54 B
Net Debt / EBITDA
~0.15x
Current Ratio
1.09
Deferred Revenue FY2025
$5.27 B
Working Capital Growth Since 2022
+43%
Operating Cash Flow FY2022
$6,554 M
Operating Cash Flow FY2023
$7,344 M
Operating Cash Flow FY2024
$8,323 M
Operating Cash Flow FY2025
$9,409 M
CapEx FY2022
($368 M)
CapEx FY2023
($345 M)
CapEx FY2024
($429 M)
CapEx FY2025
($322 M)
CapEx / Revenue
~1.2%
Free Cash Flow FY2022
$6,186 M
Free Cash Flow FY2023
$6,999 M
Free Cash Flow FY2024
$7,894 M
Free Cash Flow FY2025
$9,087 M
FCF 4-yr CAGR
~13.6%
FCF Growth 2022-2025
47%
Buybacks FY2022
($6,621 M)
Buybacks FY2023
($10,377 M)
Buybacks FY2024
($6,509 M)
Buybacks FY2025
($6,440 M)
Dividends FY2024
($1,174 M)
Dividends FY2025
($1,248 M)
Total Capital Return FY2025
~$7.7 B
Payout Ratio (% of FCF)
~85%
P/E TTM
21.68x
Forward P/E
15.77x
PEG Ratio
0.72
P/B
−13.7x
EV/EBITDA TTM
~14.2x
FCF Yield
~5.3%
Strengths
Concerns
BKNG is a high-quality, cash-generative compounder trading at a significant discount to intrinsic value with mid-teens forward P/E (15.8x), PEG below 1 (0.72), and ~5.3% FCF yield. The company generates best-in-class 34.4% TTM operating margins with $9.09B FY2025 free cash flow outpacing revenue growth, demonstrating real operating leverage. Capital return is aggressive at ~85% of FCF via $6.44B buybacks and $1.25B dividends, while balance sheet remains fortress-strong with only $1.53B net debt. Principal risks are cyclical (consumer slowdown, FX) and regulatory (EU DMA), not structural.
Macro: The macro backdrop is unambiguously supportive for travel services: Polymarket prices only a 7% chance of a US recession by year-end 2026 (down 1.5pp on the week), 89% probability of no Fed cuts in 2026 (up 0.4pp), and US unemployment above 5.0% at only 8%. Japan recession odds collapsed 13pp to 8% in a week. The 'Goldilocks no-landing' scenario — sticky/elevated rates but no recession — historically aligns with healthy consumer travel spending. All macro data is sourced from Polymarket prediction-market implied probabilities due to FRED API unavailability.